Literature DB >> 22906247

Trends and outcomes of minimally invasive surgery for gastric cancer: 750 consecutive cases in seven years at a single center.

Hoon Hur1, Yi Xuan, Chang Wook Ahn, Yong Kwan Cho, Sang-Uk Han.   

Abstract

BACKGROUND: The aims of this study were to investigate trends in minimally invasive surgery (MIS) for gastric cancer through the experience of a single center and to predict the direction of the development of MIS.
METHODS: During a 7-year period, 2,160 patients underwent curative gastric cancer surgery. Changes in the proportion and pathologic features of a total of 750 cases that involved MIS, as well as the surgical methods and outcomes of MIS, were analyzed.
RESULTS: An analysis of the patient population treated by MIS revealed that the proportion of patients with T2 or greater tumors on the basis of pathologic findings was initially <5.0% but had recently increased to 24.3%. Although the proportions of intracorporeal anastomosis and robotic surgery had recently increased, the complication rate and operative time had stabilized 2 years after the 1st MIS.
CONCLUSIONS: Given these results, the application of MIS for gastric cancer is expected to become more frequent. In addition, new modalities will be preferred by both surgeons and patients to reduce the invasiveness of gastric cancer surgery.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22906247     DOI: 10.1016/j.amjsurg.2012.03.010

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

Review 1.  Robot-assisted gastrectomy for gastric cancer: current status and technical considerations.

Authors:  Andrea Coratti; Mario Annecchiarico; Michele Di Marino; Edoardo Gentile; Francesco Coratti; Pier Cristoforo Giulianotti
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

Review 2.  [Robotic hepatobiliary and gastric surgery].

Authors:  L Milone; A Coratti; D Daskalaki; E Fernandes; P C Giulianotti
Journal:  Chirurg       Date:  2013-08       Impact factor: 0.955

3.  Effect of visceral fat area on outcomes of laparoscopyassisted distal gastrectomy for gastric cancer: subgroup analysis by gender and parameters of obesity.

Authors:  Ji-Eon Go; Min-Chan Kim; Ki-Han Kim; Jong-Young Oh; Yoo-Min Kim
Journal:  Ann Surg Treat Res       Date:  2015-05-14       Impact factor: 1.859

4.  Risk Factors for Anastomotic Leakage: A Retrospective Cohort Study in a Single Gastric Surgical Unit.

Authors:  Sung-Ho Kim; Sang-Yong Son; Young-Suk Park; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  J Gastric Cancer       Date:  2015-09-30       Impact factor: 3.720

5.  Minimally Invasive Hemostatic Materials: Tackling a Dilemma of Fluidity and Adhesion by Photopolymerization in situ.

Authors:  Yun Zhang; Dandan Song; Hong Huang; Zhiling Liang; Houhe Liu; Yugang Huang; Cheng Zhong; Guodong Ye
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

6.  Laparoscopic versus opengastric surgery for the treatment of pathological T1N0M0 gastric cancer in elderly patients: a matched study.

Authors:  Haiyan Pan; Tao Li; Zhigang Huang; Haibing Yu; Danli Kong; Yuanlin Ding; Congcong Pan; Yugang Jiang
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

Review 7.  Advances in the development of hemostatic biomaterials for medical application.

Authors:  Yong Kiel Sung; Dae Ryeong Lee; Dong June Chung
Journal:  Biomater Res       Date:  2021-11-12

8.  A Comparison of Totally Laparoscopic Pylorus Preserving Gastrectomy and Laparoscopy-Assisted Pylorus Preserving Gastrectomy for Early Gastric Cancer.

Authors:  Won Ho Han; Bang Wool Eom; Hong Man Yoon; Keun Won Ryu; Deok Hee Kim; Young-Woo Kim
Journal:  J Minim Invasive Surg       Date:  2019-09-15

9.  Outcomes of Critical Pathway in Laparoscopic and Open Surgical Treatments for Gastric Cancer Patients: Patients Selection for Fast-Track Program through Retrospective Analysis.

Authors:  Ji Woo Choi; Yi Xuan; Hoon Hur; Cheul Su Byun; Sang-Uk Han; Yong Kwan Cho
Journal:  J Gastric Cancer       Date:  2013-06-25       Impact factor: 3.720

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.